AACR IO 2026 Keynote Highlights: Cancer Vaccines Are Here, and Upgrading T Cells To Thrive in the Tumor Microenvironment
Elizabeth M. Jaffee and Philip D. Greenberg opened AACR IO 2026 with a look at cancer vaccines and the...
Elizabeth M. Jaffee and Philip D. Greenberg opened AACR IO 2026 with a look at cancer vaccines and the...
Dan Theodorescu and Lars Dyrskjøt preview the AACR's upcoming conference on bladder cancer.
International award and grant recipients from the Annual Meeting 2024 talk about defeating cancer globally.
Patient advocates at the AACR Annual meeting 2024 brought their perspectives to cancer researchers.
NCI Director Kimryn Rathmell evoked Taylor Swift to present her vision of the 360 era for cancer research.
April picks include metabolic interventions for acute myeloid leukemia, new inhibitors of KRAS signaling, and more.
A plenary session at the AACR Annual Meeting 2024 explored how metastases adapt to—and help shape—their new environments.
At the AACR Annual Meeting 2024, researchers discussed innovative approaches to decipher the complexities of tumor ecosystems.
A session at the AACR Annual Meeting 2024 offered advice on better ways to communicate science to the public....
The AACR Annual Meeting 2024 Opening Plenary showed how researchers are inspiring science, fueling progress, and revolutionizing care.
Researchers at the AACR Annual Meeting 2024 presented the latest findings regarding two personalized neoantigen cancer vaccines.